Lucia Gerena

2.7k total citations
43 papers, 2.1k citations indexed

About

Lucia Gerena is a scholar working on Public Health, Environmental and Occupational Health, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Lucia Gerena has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Public Health, Environmental and Occupational Health, 15 papers in Organic Chemistry and 13 papers in Molecular Biology. Recurrent topics in Lucia Gerena's work include Malaria Research and Control (35 papers), Mosquito-borne diseases and control (10 papers) and Computational Drug Discovery Methods (9 papers). Lucia Gerena is often cited by papers focused on Malaria Research and Control (35 papers), Mosquito-borne diseases and control (10 papers) and Computational Drug Discovery Methods (9 papers). Lucia Gerena collaborates with scholars based in United States, Thailand and Panama. Lucia Gerena's co-authors include Wilbur K. Milhous, Norman C. Waters, Dennis E. Kyle, Norma Roncal, Miriam Lopez-Sanchez, Jacob D. Johnson, Arba L. Ager, William Y. Ellis, Jonathan L. Vennerstrom and Sean T. Prigge and has published in prestigious journals such as PLoS ONE, Biochemistry and Scientific Reports.

In The Last Decade

Lucia Gerena

42 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucia Gerena United States 26 1.2k 871 538 486 254 43 2.1k
Silvia Parapini Italy 30 1.2k 1.0× 964 1.1× 728 1.4× 375 0.8× 239 0.9× 113 2.7k
Martin Schlitzer Germany 23 763 0.6× 774 0.9× 925 1.7× 364 0.7× 253 1.0× 119 2.1k
Kumkum Srivastava India 37 914 0.8× 2.2k 2.5× 956 1.8× 477 1.0× 330 1.3× 96 3.3k
Jane X. Kelly United States 23 1.2k 1.0× 685 0.8× 787 1.5× 389 0.8× 327 1.3× 40 2.5k
Arba L. Ager United States 28 1.1k 0.9× 536 0.6× 335 0.6× 353 0.7× 329 1.3× 54 1.9k
Livia Vivas United Kingdom 23 802 0.7× 605 0.7× 392 0.7× 331 0.7× 217 0.9× 41 1.6k
Paul A. Stocks United Kingdom 23 756 0.6× 621 0.7× 350 0.7× 279 0.6× 218 0.9× 33 1.4k
Christian Scheurer Switzerland 18 1.0k 0.9× 495 0.6× 376 0.7× 416 0.9× 163 0.6× 28 1.6k
Diego Monti Italy 26 663 0.6× 679 0.8× 747 1.4× 276 0.6× 137 0.5× 77 2.1k
David D. N’Da South Africa 21 544 0.5× 809 0.9× 395 0.7× 211 0.4× 186 0.7× 90 1.5k

Countries citing papers authored by Lucia Gerena

Since Specialization
Citations

This map shows the geographic impact of Lucia Gerena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucia Gerena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucia Gerena more than expected).

Fields of papers citing papers by Lucia Gerena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucia Gerena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucia Gerena. The network helps show where Lucia Gerena may publish in the future.

Co-authorship network of co-authors of Lucia Gerena

This figure shows the co-authorship network connecting the top 25 collaborators of Lucia Gerena. A scholar is included among the top collaborators of Lucia Gerena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucia Gerena. Lucia Gerena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Obaldía, Nicanor, Geoffrey S. Dow, Lucia Gerena, et al.. (2016). Altered drug susceptibility during host adaptation of a Plasmodium falciparum strain in a non-human primate model. Scientific Reports. 6(1). 21216–21216. 2 indexed citations
2.
Gutteridge, Clare E., Michael P. Kozar, Qigui Li, et al.. (2011). In vitro Biotransformation, in vivo Efficacy and Pharmacokinetics of Antimalarial Chalcones. Pharmacology. 87(1-2). 96–104. 17 indexed citations
3.
Spadafora, Carmenza, Lucia Gerena, & Karen M. Kopydlowski. (2011). Comparison of the in vitro invasive capabilities of Plasmodium falciparum schizonts isolated by Percoll gradient or using magnetic based separation. Malaria Journal. 10(1). 96–96. 14 indexed citations
4.
Milner, Erin, Jayendra B. Bhonsle, Diana Caridha, et al.. (2010). Anti-malarial activity of a non-piperidine library of next-generation quinoline methanols. Malaria Journal. 9(1). 51–51. 23 indexed citations
5.
Gutteridge, Clare E., et al.. (2010). In vitro efficacy of 7-benzylamino-1-isoquinolinamines against Plasmodium falciparum related to the efficacy of chalcones. Bioorganic & Medicinal Chemistry Letters. 21(2). 786–789. 34 indexed citations
6.
Milner, Erin, Jayendra B. Bhonsle, Diana Caridha, et al.. (2010). Structure–activity relationships amongst 4-position quinoline methanol antimalarials that inhibit the growth of drug sensitive and resistant strains of Plasmodium falciparum. Bioorganic & Medicinal Chemistry Letters. 20(4). 1347–1351. 37 indexed citations
7.
Chavchich, Marina, Lucia Gerena, Jennifer M. Peters, et al.. (2010). Role ofpfmdr1Amplification and Expression in Induction of Resistance to Artemisinin Derivatives inPlasmodium falciparum. Antimicrobial Agents and Chemotherapy. 54(6). 2455–2464. 82 indexed citations
8.
Geyer, Jeanne A., Susan M. Keenan, Philip A. Thompson, et al.. (2009). Selective inhibition of Pfmrk, a Plasmodium falciparum CDK, by antimalarial 1,3-diaryl-2-propenones. Bioorganic & Medicinal Chemistry Letters. 19(7). 1982–1985. 53 indexed citations
9.
Wipf, Peter, Steven J. Geib, Diana Caridha, et al.. (2009). Synthesis and biological evaluation of the first pentafluorosulfanyl analogs of mefloquine. Organic & Biomolecular Chemistry. 7(20). 4163–4163. 97 indexed citations
10.
Dow, Geoffrey S., Yufeng Chen, Katherine T. Andrews, et al.. (2008). Antimalarial Activity of Phenylthiazolyl-Bearing Hydroxamate-Based Histone Deacetylase Inhibitors. Antimicrobial Agents and Chemotherapy. 52(10). 3467–3477. 65 indexed citations
11.
Johnson, Jacob D., et al.. (2007). Assessment and Continued Validation of the Malaria SYBR Green I-Based Fluorescence Assay for Use in Malaria Drug Screening. Antimicrobial Agents and Chemotherapy. 51(6). 1926–1933. 272 indexed citations
12.
Keenan, Susan M., et al.. (2007). Evaluation of broad spectrum protein kinase inhibitors to probe the architecture of the malarial cyclin dependent protein kinase Pfmrk. Bioorganic & Medicinal Chemistry Letters. 17(17). 4961–4966. 16 indexed citations
13.
Li, Qigui, Lucia Gerena, Lisa Xie, et al.. (2007). Development and validation of flow cytometric measurement for parasitemia in cultures of P. falciparum vitally stained with YOYO‐1. Cytometry Part A. 71A(5). 297–307. 64 indexed citations
14.
Gutteridge, Clare E., Daniel A. Nichols, Lucia Gerena, et al.. (2006). In vitro and in vivo efficacy and in vitro metabolism of 1-phenyl-3-aryl-2-propen-1-ones against Plasmodium falciparum. Bioorganic & Medicinal Chemistry Letters. 16(21). 5682–5686. 24 indexed citations
15.
Haynes, Richard K., Ho‐Wai Chan, Lucia Gerena, et al.. (2005). Convenient Access Both to Highly Antimalaria‐Active 10‐Arylaminoartemisinins, and to 10‐Alkyl Ethers Including Artemether, Arteether, and Artelinate. ChemBioChem. 6(4). 659–667. 27 indexed citations
16.
Vennerstrom, Jonathan L., Edwin O. Nuzum, Robert E. Miller, et al.. (1999). 8-Aminoquinolines Active against Blood Stage Plasmodium falciparum In Vitro Inhibit Hematin Polymerization. Antimicrobial Agents and Chemotherapy. 43(3). 598–602. 80 indexed citations
17.
Casteel, Dee Ann, et al.. (1993). Synthesis and antimalarial evaluation of 2,3,5-trioxabicyclo[2.2.3]nonane, a model for the putative pharmacophore of artemisinin. Bioorganic & Medicinal Chemistry Letters. 3(8). 1707–1710. 6 indexed citations
18.
Vennerstrom, Jonathan L., William Y. Ellis, Arba L. Ager, et al.. (1992). Bisquinolines. 1. N,N-bis(7-chloroquinolin-4-yl)alkanediamines with potential against chloroquine-resistant malaria. Journal of Medicinal Chemistry. 35(11). 2129–2134. 97 indexed citations
19.
Casteel, Dee Ann, et al.. (1992). Synthesis and antimalarial evaluation of 2,3,5-trioxabicyclo[2.2.2]octanes, models for the putative pharmacophore of qinghaosu (artemisinin). Bioorganic & Medicinal Chemistry Letters. 2(6). 623–626. 5 indexed citations
20.
Oduola, A.M.J., et al.. (1989). Chloroquine resistant Plasmodium falciparum in indigenous residents of Cameroon. Transactions of the Royal Society of Tropical Medicine and Hygiene. 83(3). 308–310. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026